Revolutionary Cancer Vaccine Targets All Solid Tumors

Insilico Medicine receives IND clearance from FDA for ISM5939, an oral ENPP1 inhibitor treating solid tumors - EurekAlert

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors - EurekAlert